Клиническое значение определения ИЛ-6 в сыворотке крови и моче и цитохрома Р450 в ткани печени у больных хроническим гепатитом С
Диссертация
Результаты исследования используются в практической работе гепатологического и нефрологического отделений клиники нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева ММА им. И. М. Сеченова, в лекционном курсе и практических занятиях со студентами кафедры терапии и профессиональных болезней медико-профилактического факультета ММА им. И. М. Сеченова, факультета фундаментальной… Читать ещё >
Список литературы
- С.М.Абдуллаев, Ю. И. Целшцева, Л. М. Самоходская и др. Генетические маркеры предрасположенности к агрессивному течению хронического гепатита С., Вестник РАМН, 2007, № 1, с.8−13
- Апросина З.Г. Хронические диффузные заболевания печени (современные тенденции) // Клин.фармакол. и терап.- 1996.- 1.- С.14−18.
- Ахматов А.Т., C.B. Сибиряк, A.C. Симбирцев, Д. С. Сибиряк. Влияние рекомбинантного IL-1B на цитохром Р450-зависимые монооксигеназы печени и почек, взаимосвязь со специфическими нейроэндокринными эффектами. 2004. Т. 3, № 1. С. 32−38
- Бобкова И.Н., Козловская Л. В., Чеботарева H.B. Мочевые тесты воспаления и фиброза в оценке прогрессирования хронического гломерулонефрита//Качество жизни 2006-№ 4-тм 15-стр. 19−25
- Ворожбит О.Б. Виявлення позапечшкових уражень при хрошчному гепатит! С //Практична медицина, — 2003.-№ 2 -С. 33−35
- Гордовская Н.Б. Варианты поражения почек при HCV-инфекции. Гепатолог. Форум, 2005, 3, 13−15
- Т.М.Игнатова Хронический гепатит С, М- Практ. Гепатол., 2004, с. 78−96
- Игнатова Т.М., Автореф.дис.докт.мед.наук., М., 2000, с. 18
- Игнатова Т.М. Вирус гепатита С как основной этиологический фактор смешанной криоглобулинемии. Гепатолог. Форум, 2005, 3, 1113-
- Игнатова Т.М., Апросина З. Г., Серов В. В. и соавтор. Внепеченочные проявления хронического гепатита С //Тер. арх. -1998,-№ 1.-С. 9−16.
- Игнатова Т.М., Апросина З. Г., Серов В. В. и соавтор. Внепеченочные проявления хронического гепатита С //Российский медицинский журнал. 2001. — № 2. — С. 13−18
- Кетлинский С.А., Калинина Н. М. Цитокины мононуклеарных фагоцитов в регуляции реакции воспаления и иммунитета. Иммунология 1995- 3: 30−44
- Козловская Л.В., Гордовская Н. Б., Малышко Е. Ю. Клиническое значение смешанной криоглобулинемии. Рос. Мед. Журнал, 2003, 4, 11−15.-
- Козловская Л.В., Милованова С. Ю., Тэгай С. В. Криоглобулинемия. Гепатолог. Форум, 2005, 3, 2−8-
- Козловская Л.В., Гордовская Н. Б., Малышко Е. Ю. и соавт.Криоглобулинемическое поражение почек: особенности течения и леченияю-Нефрол. и диализ, 2002, т.4,№ 1, с.4−8
- Козловская Л.В., Тэгай С. В., Малышко Е. Ю. и соавт.Поражение почек, ассоциированное с вирусами гепатитов В и С.- Consilium Med., 2002, т.4, № 7, с.337−341
- Козловская Л.В. Поражение почек, ассоциированное с вирусами гепатитов В и С., М- Практ. Гепатол., 2004, с. 177−186
- Козловская Л.В., Бобокова И. Н., Щербак А. В., Чеботарева Н. В. и соавт., Клиническое значение определения в моче больных гломерулонефритом молекулярных медиаторов воспаления. Нефрология. Санкт-Петербург.- 2003.- том 7.-С.197−198.
- Козловская Л.В., Бобкова И. Н., Плиева O.K., Чеботарева Н. В. и соавт., Значение исследования в моче молекулярных медиаторов иммунного воспаления и фиброза в почке при хроническом гломерулонефрите. Тер.архив., 2004, № 9., С. 84−87
- Корнев Б.М., Пономарев А. Б., Попова E.H., Фомин В. В., Варианты поражения почек при саркоидозе. М., Медицина, 2006, № 4
- А.С.Логинов, Т. М. Царегородцева, М. М. Зотина, Т. И. Северова, Г. Н. Якимчук, Т. Ф. Федотова. Интерлейкины при хроническом вирусном гепатите, М.- Тер. архив, 2001, № 2, с. 17−20
- Лопаткина Т.Н. Хронический гепатит С : Внепеченочные проявления, особенности клинического течения, диагностика. Информ. Бюл. «Вирусшье гепатитп.»., -2000. № 2. С.5−6.
- Масалова О. В., Абдулмеджидова А. Г., Моргунов К. В. и соавт. Изменение показателей гуморального и клеточного иммунитета у пациентов с хроническим гепатитом С различной тяжести //Вопросы вирусологии, 2003, т. 48, с. 15−19
- Милованова С.Ю. Характеристика хронического гепатита С, протекающего с криоглобулинемией. Автореф.дис.канд.мед.наук., М., 2005, с.18
- Мухин H.A. и соавт., Внепеченочные проявления хронических вирусных гепатитов., МЛ., 2000., № 4
- Мухин H.A., Козловская Л. В., Малышко Е. Ю. Криоглобулинемический нефрит, ассоциированный с хронической инфекцией вируса гепатита С. Тер. Архив, 2000, 6, 1−5
- Пальцев М.А., Иванов A.A. Межклеточные взаимодействия. МедицинаМ.: 1995- 26.
- Самоходская Л.М., Игнатова Т. М., Абдуллаев С. М., Краснова Т. Н., Некрасова Т. П., Мухин H.A., Ткачук В. А. Прогностическое значение комбинации аллельных вариантов генов цитокинов и гемохроматоза у больных хроническим гепатитом С., 2007
- Сергеева Т.В., Вознесенская Т. С., Клочков С. А. Клинические проявления мезангиопролиферативного гломерулонефрита у детей. Рос. педиатр. Журнал 1999- 1: 7−10
- Сибиряк C.B., Красилова И. Л., Рябчинская Л. А. и др. К вопросу о взаимодействии иммунной системы и монооксигеназной системы // Фармакология и токсикология. — 1992. — № 4. — С. 44−48
- Сибиряк C.B. Цитокины как регуляторы цитохром Р 450-зависимых монооксигеназ. Теоретические и прикладные аспекты. Цитокины и воспаление., 2003, Т.2, № 2., С.12−21.
- Сибиряк C.B., Вахитов В. А., Курчатова H.H. Цитохром Р 450 и иммунная система. Уфа: ГИЛЕМ, 2003, с. 211
- Симбирцев А. С. Цитокины новые системы регуляции защитных реакций организма. Цитокины и воспаление., 2002, Т. 1, № 1,С. 9−16
- Тэгай C.B. Особенности поражения почек у больных с хронической инфекцией вирусов гепатита С и В, Автореф.дис.канд.мед.наук., М., 2003, с. 18
- Фрейдлин И.С. Ключевая позиция макрофагов в цитокиновой регуляторной сети. Иммунология 1995- 3: 44−48.
- Харченко Н.В., Порохницький В. Г., Топольницький B.C.// BipycHI гепатита -Кшв:Фешкс.- 2002.-296 с
- Царегородцева Т.М., Серова Т. И. Цитокины в гастроэнтерологии. М.: Анахарсис, 2003. С. 50
- Ярилин A.A. Система цитокинов и принципы ее функционирования в норме и при патологии. Иммунология 1997- 5: 714
- Agnello V. Hepothesis: the etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis С virus infection.//Springer Semin. Immunopathol., 1997, 19, 111−117-
- A Antonelli, C Ferri, P Fallahi, SM Ferrari, A Ghinoi, MT Mascia, and E Ferrannini. Extrahepatic manifestations of hepatitis C virus: the thyroid disorders. //Recenti Prog Med, Jul 2005- 96(7−8): 370−81
- Anuradha Budhu and Xin Wei Wang. The role of cytokines in hepatocellular carcinoma.// J. of Leukocyte Biology, 2006, v. 1197−1210
- Arrieta Juan Jose, Elena Rodriguez-Inigo, Nuria Ortiz-Movilla et all. In Situ Detection of Hepatitis C Virus RNA in Salivary Glands. // American Journal of Pathology. 2001−158:259−264
- Ashutosh Singh and Lillian W. Gaber. Nephrotic syndrome and chronic renal insufficiency associated with essential cryofibrinogenemia. //Nephrol. Dial. Transplant., Jun 2007- 22: 1772 1775
- Avihingsanon Y, Phumesin P, Benjachat T. et al. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.//Kidney Int. 2006 Feb-69(4):747−53.
- Barsoum Rashad S. Hepatitis C virus: from entry to renal injury— facts and potentials.// Nephrol. Dial. Transplant., Jul 2007- 22: 1840 1848.
- Bataller Ramon and David A. Brenner. Liver fibrosis. // J. Clin. Invest. 115:209−218 (2005)
- Berzofsky J.A., Ahlers J.D., Janik J., Moms J., Oh S., Terabe M., Belyakov I.M. Progress on new vaccine strategies against chronic viral infections //J.Clin.Invest., 2004, v. 114, p. 450−462. Review.
- Berendt-Obolonczyk M., E Kazimierska, and K Sworczak. Thrombocytopenia and other extrahepatic manifeststions of hepatitis C virus infection—case report. //Pol Merkur Lekarski, Jul 2006
- Berk DR., SB Mallory, EB ICeeffe, and A Ahmed. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy. //Clin Gastroenterol Hepatol, Feb 2007- 5(2): 142−51
- Boiardi L, Casali B, Farnetti E. et all., Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.//J Rheumatol. 2006 Apr-33(4):703−8.
- Brandt S.J., Bodine D.M., Dunbar C.E., Nienhuis A.W. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman’s disease in mice. //J Clin Inves 1990−86:592—9, Interleukin 6 and liver regeneration Gut 2000−47:309−312
- Cacoub P, Musset L. Mixed cryoglobulinemia //Rev Prat. 2000 Feb l-50(3):276−80. French.
- Cacoub P, Ohayon V, Sekkat S, et all. Epidemiologic and virologic study of hepatitis C virus infections in Morocco Gastroenterol //Clin Biol. 2000 Feb-24(2): 169−73. French.
- R Canada, S Chaudry, L Gaber, B Waters, A Martinez, and B Wall. Polyarteritis nodosa and cryoglobulinemic glomerulonephritis related to chronic hepatitis C. //Am J Med Sci, Jun 2006- 331(6): 329−33.
- Carlos M.P., Yamamura Y., Vu Q., Conzen K., Anderson D.E., Torres J.V. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes la or lb // Clin.Immunol., 2004, v. Ill, p. 22−27
- Couser W.G. Pathogenesis of glomerular damage in glomerulonephritis. //Nephrol Dial Transplant 1998- 13: 10−15.
- YC Chen, MC Kuo, HC Chen, YH Lai, and SJ Hwang. HCV infection complicated with nephrotic syndrome, immune complex crescentic glomerulonephritis and acute renal failure: a case report. //Kaohsiung J Med Sci, Oct 2005- 21(10): 470−4.
- Choi Jinah and J.-H. James Ou. Mechanisms of Liver Injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. //Am J Physiol Gastrointest Liver Physiol 290: G847-G851, 2006
- Dai CY, Chuang WL, Chang WY, et al. Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. //J Infect Dis. 2006 Jan 1−193(1):98−101.
- DAmico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. //Kidney Int. 1998- 54: 650.
- Dammacco F., Sansonno D., Picoli C., et.al. The cryoglobulins: an overview. //Eur. J. Clin. Invest., 2001, 31,628−638-
- JM Darling and TL Wright., Immune responses in hepatitis C: is virus or host the problem? //Curr Opin Infect Dis, Jun 2004- 17(3): 193−8.
- Descotes J. Immunomodulatory agents and hepatic drug metabolizing en zymes//Drug. Metabol. Rev., 1985., Vol.16., P. 175−183
- Dore MP, G Fattovich, AR Sepulveda, and G Realdi. Cryoglobulinemia related to hepatitis C virus infection. //Dig Dis Sci, Apr 2007- 52(4): 897−907.
- Egawa K., Yoshida M., Kasai N. An endotoxininduced serum factor that de presses hepatic aminolevulinic acid synthetase activity and cytochrome P450 levels in mice // Microbiol. Immunol. — 1981. — Vol. 25. — P. 1091−1097
- Eitner F., Westerhuis R., Burg M. et al. Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. //Kidney Int 1997- 51- 1: 69−78
- Eng MA, Kallemuchikkal U, Gorevic PD. Hepatitis C virus, autoimmunity and lymphoproliferation. //Mt Sinai J Med. 2000 Mar-67(2): 120−32.
- Falasca Katia, Claudio Ucciferri, Margherita Dalessandro, et all., Cytokine Patterns Correlate with Liver Damage in Patients with Chronic Hepatitis B and C. //Ann. Clin. Lab. Sci., Jan 2006- 36: 144 150.
- Fang C., Lindros K., Badger T. et al. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlorme thiazole // Hepatology., 1998., Vol.27., P. 1304−1310
- Fausto N. (2000): Liver regeneration. //J. Hepatol., 32 (suppl.l), 1931
- Ferry C., Zignego A.L., Pileri S.A., Cryoglobulins (review). //J. Clin. Pathol., 2002,55, 4−13-
- Fomasieri A., Li M., Armelloni S. et al. Giomerutonephrilis induced by human IgMk-IgG cryoglobutins in mice. //Lab Invest 1993- 69: 531−540.
- Franklin M., Finkle B. The influence of recombinant DNAderived human and murine interferon on mouse hepatic drug metabolism // Fund. Appl. Toxicol., 1986., Vol. 7., P. 165−169
- Fukatsu A., Matsio S., Tamai H., Sakamoto N., Matsuda T., Hirano T. Distribution of interleukin-6 in normal and diseased human kidney.//Lab. Invest., 1991, 65:61
- Gabrielli A., Mansin A., Gandola M. Et al. Clinical and histological features of chronic hepatitis C//Clin. Exp. Immunol., 1994., Vol. 97., P. 87 -93.
- A Galossi, R Guarisco, L Bellis, and C Puoti. Extrahepatic manifestations of chronic HCV infection.// J Gastrointestin Liver Dis, Mar 2007- 16(1): 65−73
- Gant Timothy W., Petra R. Baus, Bruce Clothier. Gene expression profiles associated with inflammation, fibrosis, and cholestasis in mouse liver after griseofulvin // Article, Environmental Health Perspectives, May 15,2003
- Garini G., L Allegri, F Lannuzzella, A Vaglio, and C Buzio. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies. //Acta Biomed, Jan 2007- 78(1): 51−9.
- Gasztonyi B., I Antal, E Szendy, A Par, and B Hunyady., The legal and occupational health aspects of B and C type viral hepatitis.//Orv Hetil, Dec 2005- 146(52): 2623−8.
- Gemignani F., Melli G., Inglese C. et al. Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients. //J. Peripher. Nerv. Syst., 2002, 7, 59−64
- Gertz Morie A., Giampaolo Merlini, and Steven P. Treon. Amyloidosis and Waldenstrom’s Macroglobulinemia.//Hematology, Jan 2004- 2004: 257 282.
- Ghezzi P., Saccardo B., Bianchi M. Recombinant tumor necrosis factor depresses cytochrome P450dependent microsomal drug metabolism in mice // Biochem. Biophys. Res. Commun. — 1986. — Vol. 136. — P. 316 321
- Giannelli G. and S Antonaci., Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection. //Histol Histopathol, Jul 2005- 20(3): 939−44.
- Grungreiff K, Reinhold D, Ansorge S., Serum concentrations of sIL-2R, IL-6, TGF-betal, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. //Cytokine. 1999 Dec- 11(12): 1076−80.
- K Harada, Y Akai, N Kurumatani, M Iwano, and Y Saito. Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study. //Nephron, December 1, 2002- 92(4): 824−6.
- Hasler J., Estabrook R., Murray M. et al. Human cytochromes P450 // Mol. Asp. of Medicine. — 1999. — Vol. 20. — P. 1−137
- HJ Hnatyszyn., Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. //Antivir Ther, Jan 2005- 10(1): 1−11.
- Horii Y., Iwano M., Hirata E. et al. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. //Kidney Int 1993- 39: 71−75
- Hrvacevic R., Topalov D., Stojanovic R. et al. Serum and urinary interleukin-6 levels in patients with primary glomerulonephritis. //Srp Arh Celok Lek 1996- 124- 1: 40−42
- Hterrera-Esparra, Barbosa-cisneros O., Villalobos-Hurtando R. //Lupus.-1998 .-Vol.7.-P. 154−158
- Huang H. Shiffman M., Cheung C., et al. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. // Gastroenterology. 2006. — Vol. 130. — P. 1679 — 1687.
- Huang Y.S., Hwang S.J., Chan C.Y., Wu J.C., Chao Y., Chagn F.U., Lee S.D., Serum levels of cytokines in hepatitis C -related liver disease: a longitudinal study. //Zhonghua Yi Xue Za Zhi (Taipei), 1999, 62, v.327−333
- Ito H., MD, H. Ito, MD, PhD, M. Nagano, PhD, S. Nakano, MD, PhD, Y. Shigeyoshi, MD, PhD and H. Kusaka, MD, PhD In situ identification of hepatitis C virus RNA in muscle //NEUROLOGY 2005−64:1073−1075
- Iwano M., Dohi K., Hirata E., Kurumatani N., Horii Y., Fukatsu A. Et all. Urinary levels of IL-6 in patients with active lupus nephrite.//Cl. Nephrology, 1993, vol. 40, № 1, 16−21
- IM El-Kady., Assessment of humoral immune response in patients with chronic hepatitis C virus infection. //Egypt J Immunol, Jan 2004- 11(2): 141−7.
- Kacprzyk F., Chrzanowski W. Tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with glomerulonephritis. //Pol Arch Med Wewn 1996- 96- 3: 224−233
- Karpov SIu, PE Krel', T Lopatkina, TN Krasnova, SIu Milovanova, and TN Nekrasova. Spectrum, incidence and prognostic value of systemic manifestations in chronic hepatitis C of low activity. //Ter Arkh, Jan 2005- 77(2): 59−65.
- A Kasprzak, J Seidel, R Spachacz, W Biczysko, A Malkowska, E Kaczmarek, and M Zabel. Intracellular expression of pro-inflammatory cytokines (IL-1 alpha, TNF-alpha, and IL-6) in chronic hepatitis C.//Rocz Akad Med Bialymst, Jan 2004- 49 Suppl 1: 207−9.
- Kassan Stuart S. and Haralampos M. Moutsopoulos. Clinical Manifestations and Early Diagnosis of Sjogren Syndrome.//Archives of Internal Medicine, Jun 2004- 164: 1275 1284.
- Kayali Z., Buckwold V.E., Zimmerman B., Schmidt W.N. Hepatits C, cryoglobulinemia and cirrhosis: a meta-analysis. //Hepatology, 2002,36 978−985
- Kiyosawa K, Maejima S, Homma T. Early detection of hepatobiliary cancer in mass health screening. //Nippon Rinsho. 1996 May-54(5): 1425−30.
- Knapp S, Hennig BJ, Frodsham AJ, et al. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. //Immunogenetics. 2003 Sep-55(6):362−9. Epub 2003 Aug 26.
- J Kramer, H Hennig, C Lensing, S Kruger, U Helmchen, J Steinhoff, and C Dodt. Multi-organ affecting CMV-associated cryoglobulinemic vasculitis. //Clin Nephrol, Oct 2006- 66(4): 284−90.
- Lamprecht P., Gause A, Gross W.L. Cryoglobulinemic vasculits. //Arthritis Rheum., 1999, 42, 1−9 —
- Lapinski T. W.: The levels of cytokines in HCV patients.//Arch. Immune, et Therapiae Exp., 2001,49,311−316
- Lecube Albert, Cristina Hernandez, Joan Genesca, and Rafael Simo. Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients Diabetes Care 29:1096−1101, 2006
- Lee. Y., Park U.S., Choi I., Yoon S.K., Park Y.M., Human interleukin 6 gene is activated by B virus-X protein in human hepatoma cells. //Clin. Cancer Res., 1998, 4 v.1711−1717.
- Lidove A., Cacoub P., Maisonobe T. et al. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinemia. //Ann.Rheum.Dis., 2001, 60, 290−292
- Liu H., Jones B., Bradham C., Czaja M. Increased cytochrome P450 2E1 expres sion sensitizes hepatocytes to cJunmediated cell death from TNFalpha // Am. J. Physiol. Gastrointest. Liver Physiol., 2002., Vol. 282., P. 257−266
- Lorien S. Dalrymple, Thomas Koepsell, Joshua Sampson, Tin Louie, Jason A. Dominitz, Bessie Young, and Bryan Kestenbaum. Hepatitis C Virus Infection and the Prevalence of Renal Insufficiency. //Clin. J. Am. Soc. Nephrol., Jul 2007- 2: 715 721.
- Malaguamera M., Di Fazio I., Laurino A., Ferlito L., Romano M. and Trovato B.A. (1997): Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-a treatment. //Int.J.Clin. Pharmacol.Ther., 35., 385−388
- Maniwa K., Ogushi F., Haku T. et al. Sarcoidosis associated with acute renal failure and increased levels of interleukin-6 in urine // Intern. Med.- 1998.-V. 37.-P. 757−761
- Marcellin P, Asselah T, Boyer N. fibrosis and disease progression in hepatitis C.// Hepatology. 2002- 36 (Suppl 1): 47−57
- Marcellin P., Benhamou I.P. Chronic hepatitis C// Progress in Liver Diseases Eds. I. G. Bouer, R. K. Ocknez. New York.- 1995.- Vol B. -P
- McGuinness P.H., Painter D., Davies S. and McCaughan G.W. (2000): Increases in intrahepatic CD68 positive cells, and proinflammatory cytokines (particulary interleukin 18) in chronic hepatitis C infection. //Gut, 46, 260−269
- G W McCaughan and J George. Fibrosis progression in chronic hepatitis C virus infection.//Gut, March 1, 2004- 53(3): 318 321.
- Missale G., Ferrari C., Fiaccadori F.: Cytokine mediators in acute inflammation and hronic course of viral hepatitis.//Ann. Ital. Med. Int., 1995, 10, 14−18
- Morgan E. Regulations of cytochromes P450 during inflammation and infection. Drug Metab. //Rev., 1997., Vol. 29/. P. 1129−1188
- Morgan E. Regulation of cytochrome P 450 by inflammatory mediators: why and how? //Drug. Metab. Dispos., 2001, vol. 29, P.207−212
- Morra Enrica. Cryoglobulinemia.// Hematology, Jan 2005- 2005: 368 372.
- Moorman Jonathan, Mustafa Saad, Semaan Kosseifi, and Guha Krishnaswamy. Hepatitis C Virus and the Lung: Implications for Therapy. //Chest, Oct 2005- 128: 2882 2892.
- Mrowka C., Heintz B., Sieberth H.G. VCAM-1, ICAM-1, and E-selectin in IgA nephropathy and Schonlein-Henoch syndrome: differences between tissue expression and serum concentration. //Nephron 1999- 81- 3: 256−263
- Nakamura T., Miller D., Ruoslahti E. et al. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-betal. //Kidney Int 1992- 41: 1213−122
- Naoumov N.V. Hepatitis C virus infection in Eastern Europe//Journal of Hepatology.-1999.-V.31., Suppl. 1 .-P.84−88.
- Nemni R, L Sanvito, A Quattrini, G Santuccio et all. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. //Journal of Neurology Neurosurgery and Psychiatry 2003−74:1267−1271.
- Neuman M. Apoptosis in diseases of the liver // Crit. Rev. Clin. Lab. Sei. —2001. —Vol. 38, —P. 109−166
- Noronha I.L., Niemir Z., Stein H. et al. Cytokines and growth factors in renal disease. //Nephrol Dial Transplant 1995- 10- 6: 775−786
- R. S. Obach, L. M. Cox, and L. M. Tremaine. Sertraline is metabolized by multiple cytochrome P450 enzymes monoamine oxidases, and glucoronyl transferases in human: an in vitro study .//Drug Metab. Dispos., February 1, 2005- 33(2): 262 270
- Ohta K., Takano N., Seno A. et al. Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract. //Clin Nephrol 1992- 38- 4: 185−189
- Oleksyk TK, Thio CL, Tmelove AL, et al. Single nucleotide polymorphisms and haplotypes in the ILIO region associated with HCV clearance. //Genes Immun. 2005 Jun-6(4):347−57
- Okamoto T. Suppression of cytochrome P450 gene expression in the livers of mice with concanavalin A-induced hepatitis. //2000 Apr 7−394(1): 157−61.
- Ooi B.S., Cohen D.J., Veis J.H. Biology of the mesangial cell in glomerulonephritis role of cytokines.// Proc Soc Exp Biol Med 1996- 213- 3: 230−237
- Ozen S., Saatci U., Tinaztepe K. et al. Urinary tumor necrosis factor levels in primary glomerulopathies.//Nephron 1994- 66- 3: 291−294
- Park BL, Lee HS, Kim YJ, et al. Association between interleukin 6 promoter variants and chronic hepatitis B progression. //Exp Mol Med. 2003 Apr 30−35(2):76−82
- Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C.// J Hepatol. 2001 May-34(5):730−9.
- Pouteil-Noble C., Maiza H., Dijoud F. et al. Glomerular disease associated with hepatitis C virus infection in native kidneys. //Nephrol Dial Transplant 2000- 15: 28−33.
- Powell EE, Edwards-Smith CJ, Hay JL, et al. Host genetic factors influence disease progression in chronic hepatitis C. // Hepatology. 2000. -Vol. 31(4).-P. 828−33
- Pui-Yan Kwok. Single Nucleotide Polymorphisms Methods and Protocols. // Totowa, New Jersey. P. 270
- Rashad S. Barsoum. Hepatitis C virus: from entry to renal injury— facts and potentials.//Nephrology Dialysis Transplantation 2007 22(7): 18 401 848
- Renton K., Knickle L. Regulation of hepatic cytochrome P450 during infection disease // Can. J. Physiol. Pharmacol., 1990, Vol. 68., P. 777−781
- Re V Lo, and J R Kostman. Management of chronic hepatitis C. // Postgraduate Medical Journal 2005−81:376−382
- Richardson MM, Powell EE, Barrie HD, Clouston AD, Purdie DM, Jonsson JR. A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C. // J Med Genet., 2005., Vol. 42(7)., P. 45
- Rui Sun, Tian Zhigang, Kulkarni Shalini, Gao Bin. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells on CD4+ T cell-STAT3-dependent manners. //J. Immunol. 2004. 172, N 9, c. 5648−5655.
- Ryffel B., Car B.D., Gunn H. et al. Interleukin-6 exacerbates glomerulonephritis in (NZB xNZW) F1 mice. //Am J Pathol 1994- 144- 5: 927−937
- MC Safioleas and CP Manti., Hepatitis C. An update. //Saudi Med J, Jul 2007- 28(7): 1001−6.
- Sakamoto T., Liu Z., Murase N., Ezure T. et. all (1999): Mitosis and apoptosis in the liver of interleukin 6-deficient mice after partal hepatectomy. //Hepatology, 29, 403−411
- Sansonno D., Dammacco F. Hepatitis C virus, cryoglobulinemia, and vasculitis: immune complex relations. //Lancet, 2005, 5, 227−236
- L Santoro, F Manganelli, C Briani et al. Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population.//Journal of Neurology, Neurosurgery, and Psychiatry 2006−77:626−629
- Schmidt R, Baumann F, Hanschmann H, Geissler F, and Preiss R (2001) Gender difference in ifosfamide metabolism by human liver microsomes. //Eur J Drug Metab Pharmacokinet 26: 193−200
- Schocklmann H.O., Lang S., Sterzel B. Regulation of mesangial cell proliferation. //Kidney Int 1999- 56- 4: 1199−1207
- Seeff L.B. Natural history of chronic hepatitis C. //Hepatology. 2002- 36 (Suppl 1): 35−46
- Seccull A., J Richmond, B Thomas, and H Herrman., Hepatitis C in people with mental illness: how big is the problem and how do we respond? //Australas Psychiatry, Dec 2006- 14(4): 374−8.
- Sene D., Lumal N., Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. //Metabolic Brain Disease, 2004, 19, 357−381
- Shapiro S., Gershtein V., Elias et.all. (1998): mRNA cytokine profile in peripheral blood cells from chronic hepatoitis C virus (HCV)-infected patients: effects of interferon-a (INF-a) treatment. //Clin.Exp.Immunol., 114, 55−60
- Sibiryak S., Kurchatova N., Yusopova R. et al. The 2,3,7,8tetrachIor dibenzopdioxine enhances the receptormediated apoptosis of the peripheral blood Tlumphocytes // Russian J. Immunol., 2001, Vol. 6., P. 412−414
- Siewert E., Bort R., Kluge R. et al. Hepatic cytochrome P450 downregulation during aseptic inflammation in the mouse is interleukin 6 dependent // Hepatology., 2000, Vol. 32, P. 49−55
- Shoukry N.H., Cawthon A.G., Walker C.M. Cell-mediated immunity and the outcome of hepatitis C virus infection // Annu.Rev.Microbiol., 2004, v. 58, p. 391−424
- Singh Ashutosh and Lillian W. Gaber. Nephrotic syndrome and chronic renal insufficiency associated with essential cryofibrinogenemia., //Nephrol. Dial. Transplant., Jun 2007- 22: 1772 1775.
- Song I. H" Binh. V.Q., Duy D.N., Kun J.F., Bosk T.C., Kremsner, P.G., Luty A.J. Serum cytokine profiles associated with clinical presentationin Vietnamise infected with hepatitis B virus. //J. Clin. Virol., 2003, 28 v.93−103.
- Stehman-Breen C., Johnson R.Y. Hepatitis C virus-associated glomerulonephritis. //Adv. Intern. Med., 1998, 43, 79−97
- Stehman-Breen C., Johnson R.Y. Hepatitis C virus-associated glomerulonephritis. //Advances in Internal Medicine 1998- 43: 79−97.
- Spangenberg HC and HE Blum. Vasculitis and liver disease. //Schweiz Rundsch Med Prax, Oct 2006- 95(40): 1557−62.
- Takashi Omura, Minoru Yoshiyama, Tetsuya Hayashi et all. Core Protein of Hepatitis C Virus Induces Cardiomyopathy. //Circulation Research. 2005−96:148
- Tarantino A., Campise M., Banfi G. et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. //Kidney Int 1995- 47: 618−623.
- Thomson Ed. A.W. and M.T. Lotze. //The Cytokine Handbook. London, San Diego: «Academic Press», 2003
- Tilg H., Wilmer A., Vogel W., Herold M., Nolchen B. and Judmaier J.: serum levels of cytokines in chronic liver diseases. //Gastroenterology, 1992, 103,264−274
- Tini GM, V Wuscher, and R Jeker. Hepatitis C infection with false negative serology in a patient with mixed cryoglobulinemic vasculitis. //Dtsch Med Wochenschr, Mar 2007- 132(12): 616−8.
- Torpy D., Tsigos C., Lotsikas A. J., Defensor R., Chrousos G.P. and Papanicolaou D.A.: Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans.// Metabolism, 1998, 47, 1289−1293.
- Trejo O., Ramos-Casals M., Garsia-Carrasco M. Cryoglobulinemia: study of etiologic factors and clinical and immunologic in 443 patients from a simple center. //Medicine, 2001, 8, 252−262
- Trejo O., Ramos-Casals M., Garcia-Carrasco M. et al. Cryoglobulinemia. Study of Etiologic Factors and Clinical and Immunologic Features in 443 Patients from a Single Center. //Medicine. 2001- 80: 4.
- Vassilopoulos D. and LI-I Calabrese. Extrahepatic immunological complications of hepatitis C virus infection. //AIDS, Oct 2005- 19 Suppl 3: S123−7
- Vassilopoulos D, Calabrese LH. Hepatitis C virus infection and vasculitis. Implications of antiviral and immunosuppressive therapies. //Arthritis Rheum 2002−46:585−97
- Wada T. et al. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade. //Clin Cancer Res. 2000 Feb-6(2):610−5.
- Willams J., Szentivanyi A. Pharmacokinetic and pharmacodynamic parameters affected by reticuloendothelial system cell activators // Reticuloendothel. Syst. Compr. Treatise. —N.Y., London, 1985. — Vol. 8. — P. 1−25.
- Wong Tom and Samuel S. Lee. Hepatitis C: a review for primary care physician. // CMAJ • February 28, 2006- 174 (5).h
- Wright K., Morgan E. Regulation of cytochrome P450Iicl2 expression by interleukinla, interleukin6 and dexamethasone 11 Mol. Pharmacol., 1991, Vol. 39, P. 468−474
- Yamasaki K., Taga T., Hirata Y. Cloning and expression of the human interleukin-6 (BSF-2/1FN beta 2) receptor.//Science. 1988 Aug 12−241(4867):825−8.
- Yang LQ, Li SJ, Cao YF, Man XB, Yu WF, Wang HY, Wu MC. Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases.// World J Gastroenterol., 2003 Feb-9(2):359−63.
- Yang XF, Wang NP, Zeng FD. Effects of ginkgolides on gene expression of hepatic cytochrome P-450 in rats.//Zhongguo Zhong Yao Za Zhi. 2005 Jul-30(13):1009−13.
- KF Zhang, L Zhang, XF Wu, XG Zhang, H Yu, and SQ Zhao. Pathogenesis of rat mesangial proliferative glomerulonephritis induced by anti-Thyl antibody. //Sichuan Da Xue Xue Bao Yi Xue Ban, March 1, 2004- 35(2): 188−90
- S Zickmund, SL Hillis, MJ Barnett, L Ippolito, and DR LaBrecque., Hepatitis C virus-infected patients report communication problems with physicians. //Hepatology, Apr 2004- 39(4): 999−1007.